The Evolution of SEND at AstraZeneca
Regul Toxicol Pharmacol
.
2021 Jul:123:104954.
doi: 10.1016/j.yrtph.2021.104954.
Epub 2021 May 8.
Authors
Claire Kent
1
,
Brett Coupland
1
,
Claire Barnard
2
,
Jason Schofield
3
,
Shameen Afif-Rider
4
Affiliations
1
Regulatory Safety, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK. Electronic address: SEND-Data-Management@astrazeneca.com.
2
Regulatory Safety, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Alderley Park, UK. Electronic address: SEND-Data-Management@astrazeneca.com.
3
Data Science & AI, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK. Electronic address: SEND-Data-Management@astrazeneca.com.
4
Regulatory Safety, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, USA. Electronic address: SEND-Data-Management@astrazeneca.com.
PMID:
33974947
DOI:
10.1016/j.yrtph.2021.104954
No abstract available
Keywords:
Analytics; CDISC; Data warehousing; SDTM; SEND; Submission; Toxicology; US FDA.
Publication types
Comment